文献速递临床免疫分子诊断

Orient Gene Biotech COVID-19 IgG/IgM 快速检测评估

Evaluation of the COVID-19 IgG/IgM Rapid Test from Orient Gene Biotech.
PubMed 文献 · J Clin Microbiol · 2020-07-23

该研究评估 Orient Gene Biotech COVID-19 IgG/IgM 快速检测卡(OG)并与 Abbott SARS-CoV-2 IgG 免疫分析(ASIA)比较。102 例 RT-PCR 阳性患者中,症状出现 ≥10 天样本 OG 敏感性 95.8%(95%CI 89.6-98.8),ASIA 为 90.5%(95%CI 82.8-95.6);特异性均为 100%(95%CI 93.4-100)。

要点

  • 症状出现 ≥10 天后 OG 敏感性 95.8%,与 ASIA 的 90.5% 相当。
  • OG 发现 6 例 ASIA 假阴性,其中 2 例仅 OG 检出 IgM。
  • 两法特异性均为 100%,包括地方性冠状病毒感染者。

核心结论

  • OG 性能特征表明其适合临床实验室常规使用,性能与免疫分析相当。

研究设计与样本

  • 纳入 102 例 SARS-CoV-2 RT-PCR 阳性患者,其中无症状 2 例、轻症 37 例、重症住院 35 例、ICU 28 例。
  • 特异性评估纳入 42 例既往病毒和寄生虫病及高滴度类风湿因子患者。

主要发现

  • 症状出现 ≥10 天样本 OG 敏感性 95.8%(95%CI 89.6-98.8),ASIA 敏感性 90.5%(95%CI 82.8-95.6)。
  • OG 发现 6 例 ASIA 假阴性,其中 2 例仅 OG 检出 IgM。
  • 两法特异性均为 100%(95%CI 93.4-100),包括地方性冠状病毒感染者。

关键数值与推荐

  • OG 敏感性 95.8%(95%CI 89.6-98.8),ASIA 敏感性 90.5%(95%CI 82.8-95.6),均为症状出现 ≥10 天样本。
  • 两法特异性均为 100%(95%CI 93.4-100)。

临床怎么用

  • OG 可常规用于临床实验室检测 SARS-CoV-2 IgG/IgM,性能与免疫分析相当。

局限性

  • 需在更大规模无症状人群中测试 OG 以确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While the coronavirus disease 2019 (COVID-19) pandemic has peaked in many countries already, the current challenge is to assess population immunity on a large scale. Many serological tests are available and require urgent independent validation. Here, we report performance characteristics of Orient Gene Biotech COVID-19 IgG/IgM Rapid Test Cassette (OG) and compare it to Abbott SARS-CoV-2 IgG immunoassay (ASIA). Patients (n = 102) with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase PCR (RT-PCR) were tested. The patients were asymptomatic (n = 2) or had mild (n = 37) or severe symptoms requiring hospitalization in a medical unit (n = 35) or intensive care unit (n = 28). Specificity was evaluated for 42 patients with previous viral and parasitic diseases as well as a high level of rheumatic factor. The sensitivity of OG was 95.8% (95% confidence interval [CI95%], 89.6 to 98.8) for samples collected ≥10 days after the onset of symptoms, which was equivalent to the sensitivity of ASIA of 90.5% (CI95%, 82.8 to 95.6). OG uncovered six false-negative results of ASIA, of which two had only IgM with OG. Specificity was 100% (CI95%, 93.4 to 100) with both tests on samples, including patients infected with endemic coronavirus. Overall, OG performance characteristics indicate that the test is suitable for routine use in clinical laboratories, and its performance is equivalent to that of immunoassay. Testing OG on a larger asymptomatic population may be needed to confirm these results.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Dellière S, Salmona M, Minier M, et al. Evaluation of the COVID-19 IgG/IgM Rapid Test from Orient Gene Biotech. J Clin Microbiol. 2020. PMID: 32518071. doi:10.1128/JCM.01233-20

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。